Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Die... - 0 views
-
Nathan Goodyear on 07 Jun 16NAD found to be useful in the treatment of diabetes in animal model. The positive effect is through increased Sirtuin activity